Timirbaev V Kh, Kuznetsov V A, Kontarev S I, Biriukov Iu V, Babaev S N
Anesteziol Reanimatol. 1994 Jan-Feb(1):3-5.
Kallikrein-kinin system (prekallikrein and kallikrein) has been studied in arterial and mixed venous blood of 22 patients operated on the lungs and mediastinum for suppurative processes and tumors and in 15 patients operated on for ischemic heart disease (aortocoronary bypass surgery). The study was conducted before surgery, immediately after the operation was over, and 8 to 10 hours after surgery. It has been observed that the lungs do not play an essential part in the regulation of background plasma kallikrein activity. Metabolic function as regards kallikrein manifests only with the activation of kallikrein synthesis in systemic circulation. Pathologically changed pulmonary tissue is itself a source of elevated kinin formation, whose products, in their turn, are destroyed in the organs and tissues of systemic circulation, while surgical interventions on the lungs are also accompanied by short-term enhancement of kinin release into the arterial blood.
对22例因化脓性病变和肿瘤而接受肺及纵隔手术的患者以及15例因缺血性心脏病接受手术(主动脉冠状动脉搭桥手术)的患者的动脉血和混合静脉血中的激肽释放酶-激肽系统(前激肽释放酶和激肽释放酶)进行了研究。研究在手术前、手术结束后即刻以及手术后8至10小时进行。据观察,肺在基础血浆激肽释放酶活性的调节中并非起关键作用。激肽释放酶的代谢功能仅在全身循环中激肽释放酶合成激活时才表现出来。病理改变的肺组织本身是激肽生成增加的来源,其产物继而在全身循环的器官和组织中被破坏,而对肺的手术干预也伴随着动脉血中激肽释放的短期增加。